Chord Capital
VC Fund
Thrapston, United Kingdom
Chord Capital is an independent venture investor, owned by its partners John Townsend and David Farmer. It is based in Cambridge and London. Chord Capital is a highly focused developer of selected post development-stage businesses seeking to commercialise their products. They emphasise manufacture, scale-up and commercialisation of technologies.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Chord Capital invests in
Stages Chord Capital invests in
Countries Chord Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
John Townsend
|
|||
Investment Focus
Industry
- Software 3 (43%)
- Manufacturing 3 (43%)
- Advanced Materials 2 (29%)
- Management Information Systems 2 (29%)
- Computer 1 (14%)
Stage
- Funding Round 3 (43%)
- Series B 2 (29%)
- Series C 1 (14%)
Country
- United Kingdom 4 (57%)
- China 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
John Townsend
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ForwardX Robotics
|
ForwardX Robotics is a global technology developer in the fields of AI and Robotics, with over 200 pending patents and a team of over 250, including 120 engineers of which 10 hold PhDs. With team members hailing from top universities and leading companies, ForwardX is comprised of the world’s top computer vision scientists and robotics experts asshown by its award-winning work, such as 2 1st-Place Prizes at TRECVID and 1st Place Prize for IEEE’s VOT-RT. ForwardX is committed to creating value for its customers through the development of cutting-edge Autonomous Mobile Robotics. Offering a range of solutions, ForwardX aims to address a number of significant pain points for its customers within the logistics and manufacturing industries. These pain points include rising labor costs, difficulty in finding and filling jobs, inefficient processes and low productivity, rising safety concerns, and more. For more information, visit forwardx.com. | $14.2M / Series B / Mar 21, 2019 | |
Comply Serve
|
Comply Serve is a software company offering compliance and validation solutions to highly regulated industries. The company evolved out of the world's leading provider of requirements management solutions, Telelogic AB, where the founding team discovered a significant and largely untapped market opportunity for project supply chaincompliance solutions. After 3 years spent researching the compliance market, it started trading in January 2006. | Mar 19, 2012 | |
Silver Lining Solutions
|
Silver Lining Solutions enables organisations to pinpoint and replicate the employee skills, knowledge and attributes that drive the best business outcomes - quickly, cost-effectively and at scale.Companies around the world use our unique software solutions to transform the customer experience and achieve step change improvements in salesperformance and operational efficiencies. Our teams have deep industry knowledge and extensive exposure to customer management, contact centre and back office environments. This first-hand exposure helps us see things from your point of view - we understand the challenges you face and know how to overcome them to unlock significant business benefits. | $1.2M / Aug 11, 2010 | |
Metalysis
|
Metalysis is a UK technology company, headquartered in South Yorkshire, with a solid-state process to produce valuable metal alloy powders primarily used in advanced manufacturing, aerospace and automotive applications.The process, originally invented at The University of Cambridge, UK, and commercialised by Metalysis, is more environmentallyfriendly and energy efficient than traditional melting technologies.With commercial partners in industry and academia, Metalysis uses its process to produce titanium alloys and niche, high-performance alloys of major interest in advanced manufacturing industries.The Company’s Generation 4 ("Gen 4") technological expansion takes production to industrial scale. | $6.7M / May 21, 2009 | |
Sphere Medical Holding
|
Sphere Medical Holding PLC develops, manufactures, and commercializes monitoring products for critical care environments in the United Kingdom and internationally. The company offers microanalyser platforms that are used to measure clinical analytes, including pH, glucose, potassium, sodium, calcium, oxygen, Hct, and carbon dioxide. Its productsinclude analyzers for intensive care units and operating rooms; and cardiopulmonary bypass monitors, monitoring catheters, and intravenous anaesthetic analyzers. The company's products also include systems for the intermittent analysis and continuous monitoring of blood and other fluids; and sensors for catheters or other measurement probes. Its products provide healthcare professionals the information to manage therapy and optimize patient outcomes. Sphere Medical Holding PLC was formerly known as Sphere Medical Holding Ltd. and changed its name in November 2006. The company was founded in 2002 and is based in Cambridge, the United Kingdom. | $14.9M / Aug 26, 2008 | |
Atraverda
|
Atraverda is an advanced material company that owns the intellectual property rights to a conductive ceramic known worldwide through its trademark, Ebonex®. | $13.6M / Series B / Nov 02, 2007 | |
|
Metalysis
|
Metalysis is a UK technology company, headquartered in South Yorkshire, with a solid-state process to produce valuable metal alloy powders primarily used in advanced manufacturing, aerospace and automotive applications.The process, originally invented at The University of Cambridge, UK, and commercialised by Metalysis, is more environmentallyfriendly and energy efficient than traditional melting technologies.With commercial partners in industry and academia, Metalysis uses its process to produce titanium alloys and niche, high-performance alloys of major interest in advanced manufacturing industries.The Company’s Generation 4 ("Gen 4") technological expansion takes production to industrial scale. | $27M / Series C / Jul 17, 2007 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Chord Capital invest in?
Chord Capital invests primarily in Software, Manufacturing and Advanced Materials startups, most often at Funding Round and Series B stage. Most of the 7 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Chord Capital?
Public channels for Chord Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Chord Capital?
The team at Chord Capital includes John Townsend (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
